Clinical trials
Skin clinical trials
Below are recruiting skin clinical trials, each written for real people, not researchers. We’re tracking 650 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04929912Recruiting
Registry for people treated with electroporation for cancer
This study is a real-world registry that collects information about people who have already received cancer treatment using electroporation methods. It may help researchers learn which treatments are used in practice and what outcomes people experience.
LondonAges Any age - NCT05007340Recruiting
ILD and autoimmune conditions registry and sample storage
This study collects health information and may store blood or other samples to learn more about interstitial lung disease (ILD) and autoimmune-related conditions. Joining could help researchers understand different causes of ILD and improve future care.
Montreal, QuebecAges 18 years+ - NCT05013944Recruiting
Join a patient registry to support future research
This trial is a “patient registry,” which collects health information over time to help researchers plan and run future studies. It may help by contributing your experience so new treatments can be tested more effectively.
Arlington Heights, IllinoisAges 18 years+ - NCT05033678Recruiting
Teledermoscopy and AI help review your skin spot images
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
LundAges 15 years+ - NCT05036707RecruitingPhase 1/Phase 2
Study how tick bites change immune responses
This study looks at how a person’s immune system responds after exposure to Ixodes (black-legged) tick bites. It aims to better understand the body’s early immune reaction after tick exposure, using blood tests and small skin samples.
Bethesda, MarylandAges 18–99 - NCT05042830Recruiting
Tests how birch allergy in the nose affects allergy signals in blood
This study looks at people with a birch pollen allergy to see how exposure in the nose can change allergy-related blood signals. The results may help explain why symptoms can “boost” throughout the body after nasal allergen contact.
Vienna, State of ViennaAges 18–60 - NCT05047094Recruiting
DaRT radiation plus pembrolizumab for head and neck cancer
This trial tests whether a targeted internal radiation treatment (DaRT) combined with pembrolizumab (an immune therapy) can shrink recurrent or metastatic head and neck squamous cell cancer that cannot be fully removed with surgery. It may help by making cancer more visible to the immune system while delivering localized radiation to a tumor area.
JerusalemAges 18 years+ - NCT05048862Recruiting
Brain scan and tests for neuromuscular conditions
This study compares people with neuromuscular disorders to healthy people using questionnaires and brain/neurological tests. It may help researchers understand how these conditions affect the brain and nervous system.
TaipeiAges 20 years+ - NCT05086692RecruitingPhase 1/Phase 2
Beta-only IL-2 therapy for advanced solid tumors
This Phase 1/2 study tests a beta-only version of IL-2, an immune-stimulating treatment, to shrink or control advanced or metastatic solid tumors. It’s mainly designed to check safety and to see if it can help patients by improving tumor response.
San Diego, CaliforniaAges 18 years+ - NCT05108090Recruiting
Sentinel node biopsy for head and neck skin cancer
This study checks whether a “sentinel lymph node biopsy” can help find if skin cancer in the head or neck has spread to nearby lymph nodes. It uses special dye/medicine and imaging, then removes the cancer and the sentinel node soon after scanning.
Indianapolis, IndianaAges 18 years+ - NCT05111210Recruiting
IL-23/IL-17 psoriasis treatment study to understand skin immune changes
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
Paris, Île-de-France RegionAges 18 years+ - NCT05144698RecruitingPhase 1/Phase 2
RAPA-201 cell therapy for certain advanced lung and head cancers
This Phase 1/2 trial tests RAPA-201, a personalized immune cell treatment made from your own T cells, for advanced solid tumors. It may help people whose cancer has come back after standard treatment and after an anti–PD-1/PD-L1 antibody.
Hackensack, New JerseyAges 18 years+ - NCT05210114Recruiting
Skin hydration study in people with sickle cell
This study looks at how hydrated your skin is in people with sickle cell disease. It aims to better understand skin-related changes, which may help doctors monitor health and treatments in the future.
Pittsburgh, PennsylvaniaAges 12 years+ - NCT05217160RecruitingPhase 4
KeraStat gel with morphine for non-healing painful open wounds
This study tests whether KeraStat® gel that delivers morphine through the skin can reduce pain and help manage non-healing ulcers or open wounds. You may be eligible if your wound fits specific size and depth limits and you can track pain every day.
San Antonio, TexasAges 18 years+ - NCT05273138Recruiting
Study of skin immune and support cells in systemic sclerosis
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
LilleAges 18 years+ - NCT05283993Recruiting
Hospital study following people with plasma cell disorders
This is a hospital-based study that follows people with plasma cell disorders to better understand these conditions. It mainly gathers information from patients who are confirmed to have one of several related diseases.
BeijingAges Any age - NCT05296304RecruitingPhase 1
Bexarotene plus radiation for mycosis fungoides skin lymphoma
This Phase 1 study tests whether the medicine bexarotene combined with radiotherapy can shrink or control mycosis fungoides, a skin lymphoma. It also looks at how safe the combination is and how the body handles the treatment.
Commack, New YorkAges 18 years+ - NCT05307289Recruiting
Melanoma trial studying why immunotherapy stops working
This study looks at how melanoma cells “use energy” (tumor metabolism) to understand why immunotherapy can become less effective over time. If you are starting immunotherapy for advanced skin melanoma, the results may help improve future treatments for resistance.
Nice, Alpes-maritimesAges 18 years+ - NCT05307809Recruiting
Testing inflammation markers in psoriasis with and without joint symptoms
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
PoitiersAges 18–100 - NCT05357794RecruitingPhase 2
Skin-directed radiation plus brentuximab for lymphoma skin disease
This Phase 2 trial studies whether giving very low-dose total-skin electron beam radiation at the same time as brentuximab vedotin can control mycosis fungoides (a lymphoma that affects the skin). It’s for people whose disease has returned or hasn’t responded to prior treatment, especially if the tumor marker CD30 is present.
Houston, TexasAges 18 years+ - NCT05394506Recruiting
Study of factors that affect muscle laminopathy with LMNA changes
This study looks at what influences the course of a muscle disease caused by an LMNA genetic change (a type of laminopathy). It may help researchers better understand the disease and how it affects muscle and sometimes breathing or heart function.
Bron, Auvergne-Rhône-AlpesAges 2 years+ - NCT05401292RecruitingPhase 4
Skin prep for planned foot and ankle surgery
This trial studies whether a specific skin-prep approach before elective (planned) foot and ankle surgery can help prevent infection. You may be able to take part if your surgery is not for an injury and you meet the age and health requirements.
Columbia, MissouriAges 18 years+ - NCT05492682RecruitingPhase 1
First-in-human treatment for cancer using a drug injected into tumors
This Phase 1 trial tests PeptiCRAd-1, a treatment injected into a tumor, to see how safe it is and whether it can shrink cancers. It studies people whose cancer has come back or can’t be treated with standard options.
FrankfurtAges 18 years+ - NCT05499091Recruiting
Study rare disease genetics using family and health data
This study tries to find genetic causes for rare diseases that are not yet understood. It uses a national rare-disease data bank and collects consent from patients and sometimes close family members.
AngersAges Any age
Hear when a new Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for skin?
- Yes. Clin2 currently lists 650 recruiting skin studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a skin trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a skin trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.